Login
Super Investors Visium Asset Management, LP
VA

Visium Asset Management, LP

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
—
Positions
1
Quarter ended
December 31, 2016
Filed
February 14, 2017

Reported portfolio value by quarter (15 quarters reported)

$7.32B —
Q2 13 Q1 14 Q4 14 Q3 15 Q2 16 Q4 16

$4.28B in Q2 2013 → — now. Hover for any quarter.

Holdings

As reported for the quarter ended December 31, 2016. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
N None NaN% New 0 —

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q4 2016

quarter ended December 31, 2016 · filed February 14, 2017

Company Action Shares changed Value of change % of portfolio
0 0 Exited +0 — —
N None New +0 — —

Q3 2016

quarter ended September 30, 2016 · filed November 14, 2016

Company Action Shares changed Value of change % of portfolio
L Linkedin Corp Exited −420,900 −$79.7M —
Teva Pharmaceutical Industries Ltd Exited −1,397,500 −$70.2M —
RR Randgold Resources Ltd Exited −291,800 −$32.7M —
MC Monsanto Co Exited −281,600 −$29.1M —
Endo International PLC Exited −1,841,800 −$28.7M —
Marathon Petroleum Corp Exited −674,173 −$25.6M —
BG Barrick Gold Corp Exited −1,190,300 −$25.4M —
Eldorado Gold Corp Exited −5,590,200 −$25.2M —
Y Yahoo! Inc Exited −599,853 −$22.5M —
Kbr Inc Exited −1,701,291 −$22.5M —

Showing the 10 largest of 334 changes.

Q2 2016

quarter ended June 30, 2016 · filed August 12, 2016

Company Action Shares changed Value of change % of portfolio
LO Laboratory Corp Of America Holdings Exited −2,393,525 −$280M —
AP Allergan PLC Trimmed −983,063 −$227M —
PP Pacira Pharmaceuticals Inc/de Exited −2,239,098 −$119M —
Endo International PLC Trimmed −6,668,686 −$104M —
Centene Corp Exited −1,683,727 −$104M —
Biogen Inc Exited −381,642 −$99.3M —
Neurocrine Biosciences Inc Trimmed −1,859,385 −$84.2M —
L Linkedin Corp New +420,900 +$79.7M 5.6%
ZA Zeltiq Aesthetics Inc Exited −2,871,762 −$78M —
Pfizer Inc Trimmed −2,139,412 −$75.5M —

Showing the 10 largest of 613 changes.

Q1 2016

quarter ended March 31, 2016 · filed May 16, 2016

Company Action Shares changed Value of change % of portfolio
Centene Corp New +1,683,727 +$104M 1.8%
Biogen Inc New +381,642 +$99.3M 1.7%
Gilead Sciences Inc Added +749,179 +$68.8M 1.2%
II Ishares Iboxx $ High Yield Corporate Bond ETF Exited −800,000 −$64.5M —
Perrigo Co PLC Trimmed −450,907 −$57.7M 0.6%
Brookdale Senior Living Inc Trimmed −3,596,955 −$57.1M 0.6%
RR Randgold Resources Ltd New +500,500 +$45.5M 0.8%
Humana Inc Added +240,995 +$44.1M 0.9%
Alnylam Pharmaceuticals Inc Added +690,948 +$43.4M 0.8%
LO Laboratory Corp Of America Holdings Trimmed −370,011 −$43.3M 4.8%

Showing the 10 largest of 748 changes.

Q4 2015

quarter ended December 31, 2015 · filed February 12, 2016

Company Action Shares changed Value of change % of portfolio
VP Valeant Pharmaceuticals Inte Exited −1,031,942 −$184M —
Perrigo Co PLC Trimmed −1,089,487 −$158M 1.6%
C Cigna Corp Trimmed −790,130 −$116M 0.5%
Mckesson Corp Trimmed −441,550 −$87.1M 0.6%
A Aetna Inc Trimmed −786,594 −$85M 0.2%
Brookdale Senior Living Inc Added +4,412,499 +$81.5M 1.7%
MP Momenta Pharmaceuticals Inc Trimmed −5,381,093 −$79.8M —
Biogen Inc Exited −222,802 −$65M —
Tenet Healthcare Corp Trimmed −1,741,633 −$52.8M 0.3%
PP Pacira Pharmaceuticals Inc/de Trimmed −660,374 −$50.7M 2.6%

Showing the 10 largest of 1017 changes.

Q3 2015

quarter ended September 30, 2015 · filed November 16, 2015

Company Action Shares changed Value of change % of portfolio
Perrigo Co PLC Exited −2,091,441 −$387M —
Perrigo Co PLC New +1,804,056 +$284M 3.9%
AP Allergan PLC New +997,201 +$271M 3.7%
C Cigna Corp New +1,037,712 +$140M 1.9%
Endo International PLC Added +1,493,276 +$103M 4.9%
PP Pacira Pharmaceuticals Inc Added +2,336,584 +$96M 1.7%
Tenet Healthcare Corp Added +1,917,250 +$70.8M 1.2%
Mckesson Corp Added +364,679 +$67.5M 1.6%
II Ishares Iboxx Usd High Yield New +800,000 +$66.6M 0.9%
Esperion Therapeutics Inc Exited −791,157 −$64.7M —

Showing the 10 largest of 1422 changes.

Q2 2015

quarter ended June 30, 2015 · filed August 18, 2015

Company Action Shares changed Value of change % of portfolio
AP Actavis PLC Exited −1,462,409 −$435M —
VP Valeant Pharmaceuticals Inte Added +822,217 +$183M 2.6%
Endo International PLC Added +1,970,035 +$157M 4.2%
A Aetna Inc Added +1,144,373 +$146M 2.2%
A Anthem Inc Trimmed −758,785 −$125M —
C Cigna Corp Exited −921,123 −$119M —
AS Axovant Sciences Ltd New +5,080,000 +$104M 1.5%
Brookdale Senior Living Inc New +2,478,978 +$86M 1.2%
WM Wright Medical Group Inc Exited −3,205,495 −$82.7M —
Biomarin Pharmaceutical Inc Exited −584,503 −$72.8M —

Showing the 10 largest of 1417 changes.

Q1 2015

quarter ended March 31, 2015 · filed May 15, 2015

Company Action Shares changed Value of change % of portfolio
A Allergan Inc Exited −1,732,330 −$368M —
Endo International PLC Trimmed −3,960,062 −$355M 2.3%
SP Salix Pharmaceuticals Ltd Exited −3,076,092 −$354M —
Perrigo Co PLC Added +1,575,663 +$261M 4.9%
CP Covidien PLC Exited −2,188,510 −$224M —
AP Actavis PLC Added +734,012 +$218M 6.4%
Brookdale Senior Living Inc Exited −4,234,374 −$155M —
SS SPDR S&P 500 ETF Trust Trimmed −337,700 −$149M —
TW Time Warner Cable Trimmed −132,367 −$148M —
C Cigna Corp Added +914,133 +$118M 1.8%

Showing the 10 largest of 1354 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support